Clinical Guest Contributors

  1. Repurposing Three FDA-Approved Drugs For A New Stroke Recovery Strategy 9/17/2026

    When three drugs become one — the polypharmacology strategy, 505(b)(2) pathway, and objective endpoints Nuero-Innovators is relying on to bring new hope to stroke patients.

  2. Coalition Takes Guesswork Out Of Charcot-Marie-Tooth Disease Research With New Guidance 9/16/2026

    A new Charcot-Marie-Tooth guidance introduces practical recommendations to help sponsors design clearer, more patient-centered, regulator-ready trials.

  3. How AI Will Reshape Study Start-Up 9/14/2026

    AI can help study start-up teams move from tracking delays to predicting risks—if human judgment, data quality, and governance stay central.

  4. Clinical Supply Systems Need IT General Controls 9/14/2026

    Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.

  5. Medical Affairs: The Missing Link To Oncology Drug Adoption 9/11/2026

    Learn how medical affairs can help oncology teams turn strong clinical evidence into real-world adoption by connecting development strategy with clinical practice.

  6. How Can We Influence Others For Better Outcomes In Clinical Research? 9/10/2026

    Learn how to use the Delphi method to build consensus and drive better decisions in clinical research — even when stakeholders start far apart.

  7. What Will Life Science Orgs Do When The AI Bill Comes Through? 9/9/2026

    AI is transforming clinical development, but what happens when usage costs spike? Jon Newton explains how to govern it before the bill lands.

  8. Clinical Trial Standards — What They Are And Why They're Indispensable 9/8/2026

    Clinical trial standards are essential. But to interpret changes, preserve meaning, and assess downstream impact, context is key.

  9. Last-Mile Lessons For Depot-To-Site Delivery 9/7/2026

    Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.

  10. 5 Ways To Enrich The Clinical Trial Ecosystem 9/4/2026

    Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.